Skip to main content
Clinical Trials/CTRI/2025/10/096224
CTRI/2025/10/096224RecruitingPhase 3

Study the Efficacy of Shankhapushpi (Convolvulus pluricaulis) Siddha Taila Shiroabhyanga on Mentally Stressed College Going Students.

Dr Nikita Rikame1 site in 1 country32 target enrollmentStarted: December 1, 2025Last updated:

Trial Snapshot

Phase
Phase 3
Status
Recruiting
Sponsor
Enrollment
32
Locations
1
Primary Endpoint
Relief from symptoms of Nidranasha, Mental stress and Anxiety as indicated by post-intervention scores on PSQI, PSS, and HAM-A.

Study Overview

Brief Summary

Shankhpushpi has been recognized in Ayurveda as ‘Medhya Rasayana’ meaning a drug which rejuvenates, maintains and potentiates intellect and memory**.**Shankhpushpi’s isolated compounds have also demonstrated therapeutic potential in pertaining to anti-depressants CNS depression, calmative, anti-oxidant, anti-amnesic properties & antistress activity. Convolvulus pluricaulis possess several neuropharmacological properties including nootropic, neuroprotective, anti- depressant, anti-stress, anti-inflammatory, anti-oxidant, anti- convulsant, anxiolytic, sedative, anti-Alzheimer’s, anti- Parkionson’s.

Study Design

Study Type
Interventional
Allocation
Na
Masking
None

Eligibility Criteria

Ages
18.00 Year(s) to 25.00 Year(s) (—)
Sex
All

Inclusion Criteria

  • 1.Participants with a Pittsburgh Sleep Quality Index total score between 5 and 21 2.Participants with a Perceived Stress Scale score ranging from 0 to 26 3.Those willing to perform Shiroabhyanga for 21 days will be recruited for trial.

Exclusion Criteria

  • 1.Participants contra-indicated for Shiroabhyanga such as Ajeerna and Nava Jwara.
  • 2.Known case of Participants on anti-depressants, anxiolytic medications or sedatives, etc.
  • i.e., those suffering from severe Mental illness to avoid bias.
  • 3.Known case of head trauma.
  • 4.Known case of any systemic or metabolic disorders.
  • 5.Participants undergoing detox treatment for addiction.

Outcomes

Primary Outcomes

Relief from symptoms of Nidranasha, Mental stress and Anxiety as indicated by post-intervention scores on PSQI, PSS, and HAM-A.

Time Frame: basline, 7th and 14th day

Secondary Outcomes

  • Relief from symptoms of Nidranasha, Mental stress and Anxiety as indicated by post-(basline and 21st day)

Investigators

Sponsor
Dr Nikita Rikame
Sponsor Class
Private medical college
Responsible Party
Principal Investigator
Principal Investigator

Dr Nikita Rajkumar Rikame

Bharati Vidyapeeth Deemed to be University college of Ayurved Pune

Study Sites (1)

Loading locations...

Similar Trials